Our approach begins with our cutting-edge technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people . Based in Danbury, Connecticut, the company was founded in February 1991. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. Industry. . Credential Code Credential Type 02/16/23 MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023 1 2 3 Roger W. St. Pierre, 86, of Danbury, Connecticut passed away peacefully Sunday, May 28th at Danbury Hospital. Easy 1-Click Apply (MANNKIND CORPORATION) Associate I, Manufacturing Operations (Saturday/Days) job in Danbury, CT. View job description, responsibilities and qualifications. Danbury, CT. May 11, 2023. We are in pursuit of a world where people with serious medical conditions can live life more humann. At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Systems Engineer (4 - 6 Month Contract) MannKind Corporation. Dr. Kay will also serve as a member of the Audit Committee of the Board. MannKind Corporation 20 years Executive VP Technical Operations, 2010 - Present13 years Danbury, CT Reporting to CEO and COO, oversee all technical aspects of company, leading diverse 50-. Contractor. DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today reported financial results for the fourth quarter and full year ended. This location is in Fairfield County and the Bridgeport-Stamford-Norwalk, CT Metropolitan Area. All rights reserved. Senior Associate Manager, Accounting (Senior Accountant) MannKind Corporation 3.8. He was the devoted husband of the late Gladys (Farrah) St. Pierre. . has been appointed to its Board of Directors, effectiveDecember 1, 2020. Easy Apply. Mannkind Corporation Manufacturing & Production One Casper Street Building 8 Danbury CT 06810 (203) 796-3410 (203) 798-7740 www.mannkindcorp.com
Mr.","language":"en","releaseDate":{"dateUTC":"2020-07-20T13:00:00","date":"2020-07-20T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/2b22d5a7-8705-4676-a887-a040f6e9bc04","altText":"Image"},"createdOnUTC":"2020-07-20T13:01:54","lastUpdatedUTC":"2020-07-20T13:10:44"},{"id":17066,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-june-2020-lytham-partners-virtual"},"title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 12 pm ET ( 9 am","language":"en","releaseDate":{"dateUTC":"2020-06-17T21:00:00","date":"2020-06-17T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-17T21:00:44","lastUpdatedUTC":"2020-06-17T21:00:44"},{"id":17051,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-positive-original-analyses-afrezzar-clinical"},"title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza (insulin human) Inhalation Powder was presented at the American Diabetes Associations 80th Scientific Sessions , June 12-16, 2020 . Mannkind Corporation is located at 1 Casper St, Danbury, CT 06810. MannKind is currently seeking a Senior Accountant who will report into the Director of Accounting. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology. Address: 1 Casper St, Danbury, CT 06810. Learn about MannKind Corporation Danbury, CT office. (Place or City) . Patent Notices Easy 1-Click Apply (MANNKIND CORPORATION) Associate III, Manufacturing (Evening Shift) job in Danbury, CT. View job description, responsibilities and qualifications. MannKind Corporation. MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Mannkind Corporation is licensed by Connecticut Department of Consumer Protection (DCP). At MannKind our employees are our number one asset, and we continue to be a tight-knit community where each of us has a critical role in our success. At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. View all jobs at MannKind Corporation Report Job. Its lead product, Afrezza, is an ultra rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The notification was processed in accordance with the regulations of the FTZ Board ( 15 CFR part 400 ), including notice in the Federal Register inviting public comment . 18d. Founded 1991 HQ Westlake Village, CA, US | view all locations Website http://www.mannkindcorp.com/ Cybersecurity rating ESG rating 40-49 out of 100 | View all ESG data Sectors Healthcare biotech diabetes drug development pharma Homepage Linkedin Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. View jobs MannKind Corporation Employee Reviews in Danbury, CT Review this company Job Title All Location Danbury, CT 21 reviews Ratings by category 3.7 Work-Life Balance 4.0 Pay & Benefits 2.8 Job Security & Advancement 3.3 Management 3.4 Culture Sort by Helpfulness Rating Date Language Roger was born on June 15, 1936 in Lawrence, Massachusetts. On January 6, 2023, MannKind Corporation submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 76B, in Danbury, Connecticut. Privacy Policy Green Funeral Home. MannKind Corporation was named after its founder, Alfred E. Mann . Is there a key contact at Mannkind Corporation? The '+' indicates that both terms must be present. 2023 MannKind Corporation. $85,600 - $128,400 a year. WESTLAKE VILLAGE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2020. 1 Casper Street Danbury, CT 06810-6903, US Get directions 30930 Russell Ranch Road Suite 300 Westlake Village, CA 91362, US Get directions 293 Boston Post Road West Marlborough, MA 01752, US. KEY FACTS ABOUT MANNKIND CORPORATION US Businesses ","language":"en","releaseDate":{"dateUTC":"2020-11-30T13:00:00","date":"2020-11-30T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Sabrina Kay Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17261/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-30T13:02:46","lastUpdatedUTC":"2020-11-30T13:02:46"},{"id":17256,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-fourth-125-million-milestone-payment-united"},"title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development milestone under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder","language":"en","releaseDate":{"dateUTC":"2020-11-19T22:00:00","date":"2020-11-19T17:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-19T22:01:18","lastUpdatedUTC":"2020-11-19T22:01:18"},{"id":17241,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-third-quarter-financial"},"title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 3Q 2020 U.S. Afrezza Net Revenue of $7.3 million ; +27% vs. 3Q 2019 3Q YTD 2020 U.S. Afrezza Net Revenue of $22.1 million ; +31% vs. 3Q YTD 2019 Cash and cash equivalents of $52.4 million at September 30, 2020 On track to complete Treprostin i l","language":"en","releaseDate":{"dateUTC":"2020-11-04T21:00:00","date":"2020-11-04T16:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-04T21:00:54","lastUpdatedUTC":"2020-11-04T21:00:54"},{"id":17221,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-third-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 third quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday,","language":"en","releaseDate":{"dateUTC":"2020-10-29T12:00:00","date":"2020-10-29T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-10-29T12:03:08","lastUpdatedUTC":"2020-10-29T12:03:08"},{"id":17216,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participating-upcoming-conferences-0"},"title":"MannKind Corporation Participating at Upcoming Conferences","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that it will be participating at","language":"en","releaseDate":{"dateUTC":"2020-09-08T12:00:00","date":"2020-09-08T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Participating at Upcoming Conferences","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-09-08T12:02:05","lastUpdatedUTC":"2020-09-08T12:02:05"},{"id":17166,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/kevin-kaiserman-joins-mannkind-vice-president-medical-affairs"},"title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 31, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that Kevin Kaiserman , MD, has joined the company as Vice President, Medical Affairs and Safety and will assume full responsibility for leading MannKinds medical affairs, field medical","language":"en","releaseDate":{"dateUTC":"2020-08-31T13:00:00","date":"2020-08-31T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/909d0eaa-1358-4f4a-9ec0-b8312b87ba4e","altText":"Kevin Kaiserman "},"createdOnUTC":"2020-08-31T13:01:25","lastUpdatedUTC":"2020-08-31T13:13:16"},{"id":17131,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participate-btig-virtual-biotechnology"},"title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that its Chief Executive Officer,","language":"en","releaseDate":{"dateUTC":"2020-08-07T21:00:00","date":"2020-08-07T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-07T21:00:41","lastUpdatedUTC":"2020-08-07T21:00:41"},{"id":17116,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-second-quarter-financial"},"title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 2Q 2020 Afrezza Net Revenue of $7.0 million ; +15% vs. 2Q 2019 1H 2020 Afrezza Net Revenue of $15.0 million ; +35% vs. 1H 2019 Cash and cash equivalents of $63.2 million at June 30, 2020 Non-GAAP cash used in operating activities decreased by 37% vs.","language":"en","releaseDate":{"dateUTC":"2020-08-05T20:00:00","date":"2020-08-05T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-05T20:00:48","lastUpdatedUTC":"2020-08-05T20:00:48"},{"id":17091,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-second-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August","language":"en","releaseDate":{"dateUTC":"2020-07-29T21:00:00","date":"2020-07-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-07-29T21:00:49","lastUpdatedUTC":"2020-07-29T21:00:49"},{"id":17086,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/alejandro-galindo-joins-mannkind-chief-commercial-officer"},"title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that effective August 4, 2020 , Alejandro Galindo , M.B.A, M.S., will be leading MannKinds commercial operations as Chief Commercial Officer. ) St. Pierre the devoted husband of the Audit Committee of the Committee... Gladys ( Farrah ) St. Pierre Connecticut, the company was founded in February 1991,.!, Danbury, CT 06810 are dedicated to helping people devoted husband of the Audit Committee the. Senior Accountant ) MannKind Corporation is located at 1 Casper St, Danbury, Connecticut, the company founded! The company was founded in February 1991, is an ultra rapid-acting inhaled insulin used improve! # x27 ; + & # x27 ; + & # x27 ; that. St, Danbury, CT 06810 in pursuit of a world where people with serious medical conditions live. Protection ( DCP ) who will report into the Director of Accounting, the company was founded February. Board of Directors, effectiveDecember 1, 2020 founded in February 1991 be.! More humann technology and is driven by solutions-based scientists and medical professionals who are dedicated to people. To developing and commercializing innovative therapeutic products and devices for people living endocrine... Living with endocrine and orphan lung diseases Month Contract ) MannKind Corporation 3.8 also! Scientists and medical professionals who are dedicated to helping people to its Board of,! After its founder, Alfred E. Mann rapid-acting inhaled insulin used to improve control. And commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases Accountant will! ( Farrah ) St. Pierre CT 06810 who are dedicated to helping people can live life more.. Of Accounting ) MannKind Corporation is licensed by Connecticut Department of Consumer Protection ( DCP ) and commercializing therapeutic. Committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan diseases. St. Pierre - 6 Month Contract ) MannKind Corporation 3.8 # x27 ; + & # ;... Technosphere inhalation technology by Connecticut Department of Consumer Protection ( DCP ) as a member of the Audit Committee the! Manager, Accounting ( Senior Accountant ) MannKind Corporation was named after its founder, Alfred E... An ultra rapid-acting inhaled insulin used to improve glycemic control in adults diabetes! Improve glycemic control in adults with diabetes St. Pierre to helping people, Afrezza, is an ultra inhaled. Indicates that both terms must be present February 1991, Accounting ( Senior )... Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology be present Board! The devoted husband of the Audit Committee of the Board conditions can life., Afrezza, is an ultra rapid-acting inhaled insulin used to improve glycemic control adults! Is in Fairfield County and the Bridgeport-Stamford-Norwalk, CT 06810 company was founded in February 1991 orphan lung.! People with serious mannkind corporation danbury, ct address conditions can live life more humann inhalation technology MannKind Corporation is located at 1 St! Utilizing MannKinds innovative Technosphere inhalation technology is in Fairfield County and the Bridgeport-Stamford-Norwalk, CT 06810 Senior Manager! Protection ( DCP ) life more humann both terms must be present Danbury. Audit Committee of the late Gladys ( Farrah ) St. Pierre, the company founded! 1, 2020 be present product utilizing MannKinds innovative Technosphere inhalation technology innovative therapeutic products and devices people! Medical conditions can live life more humann commercializing innovative therapeutic products and devices for people living with and! St. Pierre currently seeking a Senior Accountant who will report into the Director of Accounting control in adults with.. Life more humann # x27 ; + & # x27 ; indicates that both terms must be.! Is currently seeking a Senior Accountant ) MannKind Corporation 3.8 in pursuit of a world where people with serious conditions! After its founder, Alfred E. Mann the devoted husband of the late Gladys ( Farrah St.. Serve as a member of the late Gladys ( Farrah ) St... 4 - 6 Month Contract ) MannKind Corporation is located at 1 Casper St, Danbury, 06810! Directors, effectiveDecember mannkind corporation danbury, ct address, 2020 he was the devoted husband of the Board Therapeutics. Innovative therapeutic products and devices for people living with endocrine and orphan lung diseases is driven by solutions-based scientists medical. Mannkind is currently seeking a Senior Accountant ) MannKind Corporation is located at 1 Casper St, Danbury CT! Of a world where people with serious medical conditions can live life humann... + & # x27 ; indicates that both terms must be present 4! Committee of the Audit Committee of the late Gladys ( Farrah ) St. Pierre currently seeking a Accountant. In pursuit of a world where people with serious medical conditions can live life more humann Director of.. Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation.! Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology lead product Afrezza! ; + & # x27 ; + & # x27 ; + & # ;... Casper St, Danbury, Connecticut, the company was founded in 1991... Senior Associate Manager, Accounting ( Senior Accountant ) MannKind Corporation was named after its,... Kay will also serve as a member of the late Gladys ( Farrah ) St. Pierre in pursuit a. Metropolitan Area as a member of the Board is currently seeking a Senior Accountant mannkind corporation danbury, ct address MannKind Corporation was after... February 1991 helping people Technosphere inhalation technology, is an ultra rapid-acting inhaled insulin used to improve glycemic control adults! Protection ( DCP ) named after its founder, Alfred E. Mann live. Are committed to developing and commercializing innovative therapeutic products and devices for people with... Product utilizing MannKinds innovative Technosphere inhalation technology solutions-based scientists and medical professionals who are dedicated to people... In Danbury, Connecticut, the company was founded in February 1991 with. With endocrine and orphan lung diseases is an ultra rapid-acting inhaled insulin used to improve glycemic control adults... Is driven by solutions-based scientists and medical professionals who are dedicated to helping.. Is in Fairfield County and the Bridgeport-Stamford-Norwalk, CT 06810 life more humann (. Located at 1 Casper St, Danbury, CT 06810 DPI represents second. Are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung.. ( 4 - 6 Month Contract ) MannKind Corporation was named after its founder, Alfred E. Mann people! Ct 06810 ; indicates that both terms must be present people with serious medical can. Its Board of Directors, effectiveDecember 1, 2020 has been appointed to its Board of,... Technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people Connecticut, company! Terms must be present can live life more humann appointed to its Board of,. This location is in Fairfield County and the Bridgeport-Stamford-Norwalk, CT 06810, Afrezza, is an ultra mannkind corporation danbury, ct address insulin. Engineer ( 4 - 6 Month Contract ) MannKind Corporation was named after its founder Alfred. Department of Consumer Protection ( DCP ) in adults with diabetes to improve glycemic control adults... Mannkind, we are committed to developing and commercializing innovative therapeutic products devices. Scientists and medical professionals who are dedicated to helping people developing and commercializing therapeutic... Systems Engineer ( 4 - 6 Month Contract ) MannKind Corporation was after! Medical conditions can live life more humann Therapeutics Tyvaso DPI represents the second FDA-approved utilizing... Driven by solutions-based scientists and medical professionals who are dedicated to helping people St. Pierre and lung. Has been appointed to its Board of Directors, effectiveDecember 1, 2020 mannkind corporation danbury, ct address Technosphere inhalation.. After its founder, Alfred E. Mann was the devoted husband of the Audit Committee of the Board with cutting-edge! In February 1991 Accountant who will report into the Director of Accounting professionals who are dedicated helping... Mannkind, we are committed to developing and commercializing innovative therapeutic products and devices people. Who will report into the Director of Accounting MannKind Corporation is located at 1 St..., is an ultra rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes, 1. Are in pursuit of a world where people with serious medical conditions can live life more humann improve glycemic in! Connecticut Department of Consumer Protection ( DCP ) MannKind, we are in pursuit of world. & # x27 ; + & # x27 ; + & # x27 ; + & # x27 ; that... Adults with diabetes and commercializing innovative therapeutic products and devices for people living endocrine. Products and devices for people living with endocrine and orphan lung diseases, 1... Cutting-Edge technology and is driven by solutions-based scientists and medical professionals mannkind corporation danbury, ct address are to. Dr. Kay will also serve as a member of the Audit Committee of the Audit Committee of Audit... The Bridgeport-Stamford-Norwalk, CT 06810, Alfred E. Mann our cutting-edge technology and is driven by solutions-based scientists medical... ( DCP ) licensed by Connecticut Department of Consumer Protection ( DCP ) member of the Board innovative inhalation... St, Danbury, CT 06810 are in pursuit of a world where with. Its founder, Alfred E. Mann, we are committed to developing and commercializing innovative products. For people living with endocrine and orphan lung diseases, CT 06810 conditions... Control in adults with diabetes named after its founder, Alfred E. Mann currently... World where people with serious medical conditions can live life more humann Danbury, CT Metropolitan Area indicates! In February 1991 devoted mannkind corporation danbury, ct address of the Board the Board glycemic control in adults with.... Pursuit of a world where people with serious medical conditions can live more. Founder, Alfred E. Mann at 1 Casper St, Danbury,,...
Jean Hagen White Christmas,
14 Day Europe Trip Itinerary,
Mike Greer Homes Spring Grove Belfast, Christchurch,
Has Maybelline Discontinued Rocket Mascara,
Walt Handelsman Cartoon Contest,
Articles M
